Ratings Spectra Systems Corporation

Equities

SPSY

US84756T1060

Delayed London S.E. Other stock markets 04:13:21 2024-05-08 am EDT			5-day change	1st Jan Change
233.2 ^GBX	+1.39%		+5.52%	+0.09%

May. 06	Time to Start Selling US Dollars Says Spectra Markets' Brent Donnelly	MT
May. 03	USD/JPY Now a Sell Rallies Trade, Spectra Markets' Brent Donnelly Says	MT

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

The prospective high growth for the next fiscal years is among the main assets of the company
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Over the past four months, analysts' average price target has been revised upwards significantly.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

The company's enterprise value to sales, at 4.61 times its current sales, is high.

Ratings chart - Surperformance

Sector: Business Support Services

	1st Jan change	Capi.	ESG Refinitiv
SPECTRA SYSTEMS CORPORATION	+0.09%	138M	-
CINTAS CORPORATION	+14.95%	70.29B	B+
JACOBS SOLUTIONS INC.	+9.12%	17.8B	B+
BUREAU VERITAS SA	+23.48%	13.68B	A-
RB GLOBAL, INC.	+7.46%	13.15B	B-
INTERTEK GROUP PLC	+18.82%	10.13B	B-
GENPACT LIMITED	-6.34%	5.86B	A-
MAXIMUS, INC.	+0.47%	5.14B	B-
EXLSERVICE HOLDINGS, INC.	-0.49%	4.99B	A-
EXPONENT, INC.	+7.54%	4.8B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes